Price T Rowe Associates Inc. MD Sells 131,042 Shares of Bath & Body Works, Inc. $BBWI

Key Points

• Price T Rowe Associates Inc. MD has decreased its stake in Bath & Body Works, Inc. by 1.5%, owning 8,363,047 shares worth approximately $253.57 million after selling 131,042 shares during the first quarter.
• Bath & Body Works reported $1.40 billion in revenue for the quarter, slightly below analysts' expectations, but provided positive earnings per share of $0.49, beating consensus estimates.
• The company announced a quarterly dividend of $0.20, representing an annual yield of 2.6%, to be paid to shareholders of record on August 22.

Price T Rowe Associates Inc. MD lowered its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 1.5% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 8,363,047 shares of the company's stock after selling 131,042 shares during the period. Price T Rowe Associates Inc. MD owned approximately 3.93% of Bath & Body Works worth $253,568,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the stock. Golden State Wealth Management LLC boosted its holdings in shares of Bath & Body Works by 94.7% during the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock worth $40,000 after acquiring an additional 642 shares during the period. UMB Bank n.a. grew its position in shares of Bath & Body Works by 65.9% in the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after purchasing an additional 596 shares during the last quarter. Ancora Advisors LLC acquired a new position in shares of Bath & Body Works in the fourth quarter valued at approximately $67,000. GKV Capital Management Co. Inc. acquired a new position in shares of Bath & Body Works in the first quarter valued at approximately $69,000. Finally, Brooklyn Investment Group grew its position in shares of Bath & Body Works by 394.9% in the first quarter. Brooklyn Investment Group now owns 2,697 shares of the company's stock valued at $82,000 after purchasing an additional 2,152 shares during the last quarter. 95.14% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. The Goldman Sachs Group decreased their target price on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating on the stock in a research report on Friday, May 30th. Wall Street Zen lowered shares of Bath & Body Works from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. UBS Group lifted their price objective on shares of Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a research note on Tuesday, May 20th. JPMorgan Chase & Co. increased their target price on shares of Bath & Body Works from $40.00 to $46.00 and gave the stock an "overweight" rating in a research report on Monday, July 28th. Finally, Morgan Stanley lowered their target price on shares of Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating on the stock in a report on Tuesday, May 6th. Fourteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $42.06.

Bath & Body Works Stock Performance

Shares of NYSE BBWI traded up $0.29 during trading hours on Wednesday, hitting $31.64. 9,079,244 shares of the stock were exchanged, compared to its average volume of 5,118,737. The company has a market cap of $6.70 billion, a PE ratio of 8.44, a price-to-earnings-growth ratio of 1.04 and a beta of 1.54. The company's fifty day simple moving average is $30.49 and its two-hundred day simple moving average is $30.90. Bath & Body Works, Inc. has a 1-year low of $24.94 and a 1-year high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.02. The business had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.42 billion. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The firm's revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter last year, the business posted $0.38 EPS. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. As a group, sell-side analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 5th. Investors of record on Friday, August 22nd will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, August 22nd. This represents a $0.80 annualized dividend and a yield of 2.5%. Bath & Body Works's dividend payout ratio is presently 21.33%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.